A 57-year-old male with diffuse astrocytoma in the lateral ventricle: case report.

Exploiting Metabolic Dependencies for Therapeutic Targeting of Brain Cancers.

Eloquent glioma resection assisted by brain connectomics: A new tool for awake neurosurgery.

Pediatric low-grade epilepsy-associated tumors (LEATS): neuroimaging review and genetics update.

Treatment differences in IDH-wildtype glioma - the impact of surgery and adjuvant therapy.

Diffuse astrocytoma presenting with parkinsonism and gliomatosis-like infiltration.

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.

Case Report: FGFR1 mutation and massive chromosome loss drive malignant transformation of low-grade gliomas.

Pediatric Diffuse Low-Grade Gliomas: Radiology, Symptoms, Treatment, and Molecular Pathways.

Pediatric-Type Diffuse Low Grade Glioma.

A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomas.

MOLECULAR MARKERS IN PREDICTING THE OUTCOME OF DIFFUSE GLIOMA GRADE 4 TREATMENT.

Case Report: Metabolic alterations and cholesterol esterification in a low-grade diffuse astrocytoma patient who progressed to glioblastoma at recurrence.

Coexistence of IDH1 Mutation and KIAA1549::BRAF Fusion in a Diffuse Glioma: A Case Report With Clinical, Radiological, and Pathological Correlation.

Novel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions.

Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes.

Molecular alterations in IDH-mutant astrocytoma: A multi-institutional retrospective study.

Pediatric-Type Diffuse Low-Grade Gliomas with MYB Alterations: Neuroimaging of the Diffuse Astrocytomas, MYB- or MYBL1-Altered.

Patterns of response following gamma knife radiosurgery for tectal plate gliomas.

Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients.

High-Grade Glioma With Parotid Metastasis: A Case Report of Long-Term Treatment and Follow-Up.

Multi-center real-world data-driven web calculator for predicting outcomes in IDH-mutant gliomas: Integrating molecular subtypes and treatment modalities.

Do clinical outcomes in individuals with malignant gliomas differ between sexes?

Free-hand Frameless Pinless Electromagnetic-Navigation (AXIEM™)-Guided Brain Lesion Biopsies: An Institution Based Experience from a Low-Middle-Income Country.

Gliomatosis Cerebri Manifested as Parkinsonism Syndrome: A Case Report.

Q-Ball high-resolution fiber tractography: Optimizing corticospinal tract delineation near gliomas and its role in the prediction of postoperative motor deficits- A proof of concept study.

A Case of Anterior Cingulotomy for Intractable Pain Caused Thalamic Glioma.

Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese Patients.

High-Grade Thalamic Glioma: Case Report with Literature Review.

Recent updates in pediatric diffuse glioma classification: insights and conclusions from the WHO 5th edition.

MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genes.

Current progress of anti‑PD‑1/PDL1 immunotherapy for glioblastoma (Review).

Optimal treatment strategy for low-grade spinal cord astrocytoma: a retrospective, multicenter analysis by the Neurospinal Society of Japan.

Vorasidenib-Induced Trichomegaly and Hypertrichosis: a New Side Effect in a Patient with Diffuse Astrocytoma.

The Role of Radiotherapy, Chemotherapy, and Targeted Therapies in Adult Intramedullary Spinal Cord Tumors.

Filling the gap: brief neuropsychological assessment protocol for glioma patients undergoing awake surgeries.

Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations.

Radiation-Induced Low-Grade Glioma following Radiotherapy for Squamous Cell Carcinoma of the Scalp: Case Report and Literature Review.

Deep Residual Learning-Based Classification with Identification of Incorrect Predictions and Quantification of Cellularity and Nuclear Morphological Features in Digital Pathological Images of Common Astrocytic Tumors.

FANCM Gene Variants in a Male Diagnosed with Sertoli Cell-Only Syndrome and Diffuse Astrocytoma.

Pediatric-type diffuse low-grade gliomas.

Case report: A 53-year-old woman with synchronous WHO classification II and IV gliomas.

Development of Predicting Nomograms for Diffuse Astrocytoma and Anaplastic Astrocytoma: A Study Based on the Surveillance, Epidemiology, and End Results Database.

Whole Spinal Cord FDG Uptake at PET/CT Caused by H3K27-Altered Diffuse Midline Glioma in an Adult Patient.

Bilateral tinnitus associated with a diffuse astrocytoma of Heschl's gyrus: a case report and review of literature.

T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1-Altered Diffuse Astrocytoma or Angiocentric Glioma.

Metastases and Primary Brain Tumors Affecting the Fornix of the Brain.

Neurophysiotherapy in Grade II Diffuse Astrocytoma: A Case Report.

Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma.

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.

Long-term epilepsy associated-tumors (LEATs): what is new?

Astrocytoma Mimicking Herpetic Meningoencephalitis: The Role of Non-Invasive Multimodal Monitoring in Neurointensivism.

Leat-associated seizures the possible role of EAAT2, pyruvate carboxylase and glutamine synthetase.

The T2-FLAIR mismatch sign in oncologic neuroradiology: History, current use, emerging data, and future directions.

Review on neuroimaging in pediatric-type diffuse low-grade gliomas.

Role of endoscopic third ventriculostomy in patients undergoing resection of pulvinar area lesions: Preliminary clinical results.

Proton MR spectroscopy shows improved performance to segregate high-grade astrocytoma subgroups when defined with the new 2021 World Health Organization classification of central nervous system tumors.

Cytopathology of glioneuronal and neuronal tumours with histological correlations.

Treatments associated with all-cause mortality among children with primary brain and central nervous system tumors: a retrospective cohort study from the SEER database.

[Tyrosine kinase receptor gene fusion: A series of four cases of infantile-type hemispheric glioma].

Unreported branching pattern of the triplicated anterior cerebral artery associated with multiple bilateral variants of the superior cerebellar artery detected by computed tomography angiography and 3D modeling.

Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.

Characterization of tumor-associated reactive astrocytes in gliomas by single-cell and bulk tumor sequencing.

Awake Craniotomy for Resection of Diffuse Astrocytoma During Pregnancy: A Case Report.

Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.

Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors.

DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy.

Overexpression of Podoplanin Predicts Poor Prognosis in Patients With Glioma.

Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report.

2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.

[Report of Multidisciplinary Treatment for Sisters with Li-Fraumeni Syndrome].

Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome.

Malignant transformation in low-grade astrocytoma for long-term monitoring.

An MRI-based joint model of radiomics and spatial distribution differentiates autoimmune encephalitis from low-grade diffuse astrocytoma.

Resilience in Lower Grade Glioma Patients.

T2-Fluid-Attenuated Inversion Recovery (FLAIR) Mismatch as a Novel Specific MRI Marker for Adult Low-Grade Glioma (LGG): A Case Report.

Surgical techniques and function outcome for cingulate gyrus glioma, how we do it.

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma.

The Mean ApoC1 Serum Level in Postoperative Samples from Neurosurgical Patients Is Lower than in Preoperative Samples and during Chemotherapy.

Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.

True anaplastic oligoastrocytoma with dual genotype: illustrative case.

5-Aminolevulinic Acid-A Biomarker for Worse Prognosis in IDH-Wildtype II Tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: A Case Report.

MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.

Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients.

Polish and New Zealand Propolis as Sources of Antioxidant Compounds Inhibit Glioblastoma (T98G, LN-18) Cell Lines and Astrocytoma Cells Derived from Patient.

Risk Factors Associated with Malignant Transformation of Astrocytoma: Competing Risk Regression Analysis.

The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases.

Atypical NMDA receptor expression in a diffuse astrocytoma, MYB- or MYBL1-altered as a trigger for autoimmune encephalitis.

The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.

[Algorithm for the integrated diagnosis of gliomas 2021. Our experience].

Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors.

Pediatric-type diffuse low grade gliomas: Histomolecular profile and practical approach to their integrated diagnosis according to the WHO CNS5 classification.

Epidemiological characteristics of central nervous system tumors in children: a 5-year review of 3180 cases from Beijing Tiantan Hospital.

Combined Treatment With Radiotherapy and Immunotherapy for Isocitrate Dehydrogenase Mutant Brainstem Glioma in Adult: A Case Report.

Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma.

Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance.

Diffuse astrocytoma with mosaic IDH1-R132H-mutant immuno-phenotype and low subclonal allele frequency.

Rare simultaneous occurrence of a ganglioglioma and diffuse astrocytoma with distinct molecular features in a teenager with neurofibromatosis type 1.

The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.

Malignant Progression of Diffuse Low-grade Gliomas: A Systematic Review and Meta-analysis on Incidence and Related Factors.

β-Catenin marks proliferating endothelial cells in glioblastoma.

A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient.

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study.

Young adult males have worse survival than females that is largely independent of treatment received for many types of central nervous system tumors: A National Cancer Database analysis.

Malignant Progression of an IDH Mutant Brainstem Glioma in Adult.

FISH analyses for 1p and 19q status on gliomas: Reporting an 8 years' experience from a tertiary care center in the Middle East.

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.

Early atypical malignant transformation of diffuse low-grade astrocytoma: The importance of genotyping.

Plasma-Derived Extracellular Vesicles Reveal Galectin-3 Binding Protein as Potential Biomarker for Early Detection of Glioma.

Hypermethylation of the Promoter of miR-338-5p Mediates Aberrant Expression of ETS-1 and Is Correlated With Disease Severity Of Astrocytoma Patients.

An Updated Comparison Between World Health Organization Grade II Gemistocytic and Diffuse Astrocytoma Survival and Treatment Patterns.

Radiologic-pathologic association of tumor-like lesions with inflammation in cerebral white matter: Comparison of two cases with distinct clinical outcomes.

THE SAFETY AND EFFICACY OF ROBOT-ASSISTED STEREOTACTIC BIOPSY FOR BRAIN GLIOMA: EARLIEST INSTITUTIONAL EXPERIENCES AND EVALUATION OF LITERATURE.

Fractal analysis of 11C-methionine PET in patients with newly diagnosed glioma.

Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma.

Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review.

The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study.

Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.

Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology.

Diagnosis and Individualized Treatment of Three Primary Malignant Tumors: A Case Report.

Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma.

Tumor treating fields combined with a poly (adenosine diphosphate-ribose) polymerase inhibitor during radiotherapy for rapidly progressing IDH-wildtype diffuse astrocytoma: a case report.

Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.

Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.

Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas.

Differential expression of stem cell markers in proliferating cells in glioma.

Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience.

[Dynamic11C-methionine PET/CT in differential diagnosis of brain gliomas].

Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas.

Sotos syndrome: a pitfall in the presurgical workup of temporal lobe epilepsy.

Spatial concordance of DNA methylation classification in diffuse glioma.

Gliomas - An experience based on molecular markers.

Can permanent cell lines originate from low-grade astrocytomas: overgrowth of "glia-like" cells in pilocytic and fibrillary (diffuse) astrocytoma cultures.

Diffusion MRI in Evaluation of Pediatric Posterior Fossa Tumors.

[Phosphorus MR spectroscopy and 18F-FDG PET/CT in the study of energy metabolism of glial tumors].

A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.

Residential proximity to pesticide application as a risk factor for childhood central nervous system tumors.

Anaplastic astrocytoma during pregnancy: the importance of an effective multidisciplinary approach.

IDH-mutant gliomas with additional class-defining molecular events.

A Simple Panel of IDH1 and P53 in Differential Diagnosis Between Low-Grade Astrocytoma and Reactive Gliosis.

Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity.

Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.

T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.

Resolving mystery behind autonomous retrogression of low-grade gliomas: A systematic review.

High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.

Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.

TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.

Serum cytokines in astrocytic brain tumors: a prospective study.

Diffuse astrocytoma and the diagnostic dilemma of an unusual phenotype: A case report.

Evaluation of the melting temperature of TaqMan probes as a genotyping method for IDH1, IDH2, and H3F3A in pediatric astrocytomas.

IDH-wildtype secondary glioblastoma arising in IDH-mutant diffuse astrocytoma: a case report.

Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.

[Diffuse Astrocytoma with Malignant Progression after Long-term Temozolomide Monotherapy:A Case Report].

A Case of Diffuse Astrocytoma with 32-year Survival after Boron Neutron Capture Therapy.

Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.

A juvenile case of epilepsy-associated, isocitrate dehydrogenase wild-type/histone 3 wild-type diffuse glioma with a rare BRAF A598T mutation.

Histopathological Spectrum of Central Nervous System Tumors: an Experience at a Hospital in Nepal.

[Diffuse Leptomeningeal Glioneuronal Tumor with Subarachnoid Hemorrhage:A Case Report].

Risk Stratification in Low Grade Glioma: A Single Institutional Experience.

ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.

Surgical treatment of low-grade brain tumors associated with epilepsy.

99mTc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans.

Pediatric Low-Grade Gliomas.

The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.

Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.

Unexpected discovery of a diffuse astrocytoma of the conus medullaris in an elderly NF1 patient.

Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience.

1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.

Textiloma Mimicking a Recurrent High-Grade Astrocytoma: A Case Report.

T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor.

Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma.

High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas.

Morphological and immunophenotypic characterization of perivascular interstitial cells in human glioma: Telocytes, pericytes, and mixed immunophenotypes.

Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.

Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis.

Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma.

Immunohistochemical Expression of Epidermal Growth Factor Receptor in Astrocytic Tumors in Iraqi Patients.

Molecular Aberrations Associated with Seizure Control in Diffuse Astrocytic and Oligodendroglial Tumors.

Epithelioid glioblastoma presenting as multicentric glioma: A case report and review of the literature.

Seizure freedom from recurrent insular low-grade glioma following laser interstitial thermal therapy.

Spinal rosette-forming glioneuronal tumor: A case report.

Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis.

Giant Cell-rich Tanycytic Ependymoma as Intramedullary Spinal Mass.

The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01.

Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort.

Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Eliciting Smiles and Laughter During Intraoperative Electric Stimulation of the Cingulum: Surgical Scenario.

An autopsy case of widespread brain dissemination of glioblastoma unnoticed by magnetic resonance imaging after treatment with bevacizumab.

Usefulness and safety from stereotactic biopsy in posterior fossa lesions in adult patients.

Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases.

Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.

Clinical Significance of Molecular Diagnosis of Pilocytic Astrocytoma: A Case Report.

Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification.

Tumor-associated status epilepticus in patients with glioma: Clinical characteristics and outcomes.

Brain cancer survival in Canada 1996-2008: effects of sociodemographic characteristics.